Literature DB >> 11311175

Subtyping of panic disorder patients with bradycardia.

J Massana1, J A López Risueño, G Masana, T Marcos, L González, A Otero.   

Abstract

PURPOSE: Since clinical practice suggests that panic disorder may not be a homogeneous condition, a study was carried out to test the possible existence of different groups or subgroups of panic patients. SUBJECTS AND METHODS: Thirty-two panic patients (DSM-III-R) underwent lactate challenge in our laboratory and were assessed for heart rate, blood pressure, sweating and Acute Panic Inventory.
RESULTS: During the lactate challenge, patients complaining mainly of 'cardiorespiratory' symptoms (N = 12) showed tachycardia and localized sweating. Conversely, patients complaining mainly of 'pseudoneurological' symptoms (N = 16) showed bradycardia and generalized sweating. In both groups, Acute Panic Inventory scores were significantly higher during than before the panic attack, but the distribution of the scores was markedly different. DISCUSSION AND
CONCLUSION: The results suggest that panic disorder may be a heterogeneous condition. Implications of these results to other phobic disorders, to Klein's false suffocation alarm theory and to the 'extended amygdala model' are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11311175     DOI: 10.1016/s0924-9338(01)00547-8

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  3 in total

1.  The Khmer 'Weak Heart' Syndrome: Fear of Death from Palpitations.

Authors:  Devon Hinton; Susan Hinton; Khin Um; Audria Chea; Sophia Sak
Journal:  Transcult Psychiatry       Date:  2002-09

2.  OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.

Authors:  Philip L Johnson; Lauren M Federici; Stephanie D Fitz; John J Renger; Brock Shireman; Christopher J Winrow; Pascal Bonaventure; Anantha Shekhar
Journal:  Depress Anxiety       Date:  2015-08-19       Impact factor: 6.505

3.  Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder.

Authors:  Na Du; Xue-Li Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-06       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.